These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9741456)

  • 21. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
    Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
    FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma.
    Gelderman KA; Kuppen PJ; Bruin W; Fleuren GJ; Gorter A
    Eur J Immunol; 2002 Jan; 32(1):128-35. PubMed ID: 11754353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
    Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
    Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DAF/CD55 and Protectin/CD59 modulate adaptive immunity and disease outcome in experimental autoimmune myasthenia gravis.
    Soltys J; Halperin JA; Xuebin Q
    J Neuroimmunol; 2012 Mar; 244(1-2):63-9. PubMed ID: 22325826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
    Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization.
    Li Y; Parks GD
    Viruses; 2018 Apr; 10(5):. PubMed ID: 29693588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of functional decay-accelerating factor (CD55) in transgenic mice protects against human complement-mediated attack.
    van Denderen BJ; Pearse MJ; Katerelos M; Nottle MB; Du ZT; Aminian A; Adam WR; Shenoy-Scaria A; Lublin DM; Shinkel TA; d'Apice AJ
    Transplantation; 1996 Feb; 61(4):582-8. PubMed ID: 8610385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The inhibitory effect of CD46, CD55, and CD59 on complement activation after immunotherapeutic treatment of cervical carcinoma cells with monoclonal antibodies or bispecific monoclonal antibodies.
    Gelderman KA; Blok VT; Fleuren GJ; Gorter A
    Lab Invest; 2002 Apr; 82(4):483-93. PubMed ID: 11950905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered Expression of Complement Regulatory Proteins CD35, CD46, CD55, and CD59 on Leukocyte Subsets in Individuals Suffering From Coronary Artery Disease.
    Mishra N; Mohata M; Narang R; Lakshmy R; Hazarika A; Pandey RM; Das N; Luthra K
    Front Immunol; 2019; 10():2072. PubMed ID: 31555286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and functional analysis of glycosyl-phosphatidyl inositol-linked CD46 in transgenic mice.
    Shinkel TA; Cowan PJ; Barlow H; Aminian A; Romanella M; Lublin DM; Pearse MJ; d'Apice AJ
    Transplantation; 1998 Dec; 66(11):1401-6. PubMed ID: 9869079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse CD4+ CD25+ T regulatory cells are protected from autologous complement mediated injury by Crry and CD59.
    Li Q; Nacion K; Bu H; Lin F
    Biochem Biophys Res Commun; 2009 Apr; 382(1):223-6. PubMed ID: 19281793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBXIP upregulates CD46, CD55 and CD59 through ERK1/2/NF-κB signaling to protect breast cancer cells from complement attack.
    Cui W; Zhao Y; Shan C; Kong G; Hu N; Zhang Y; Zhang S; Zhang W; Zhang Y; Zhang X; Ye L
    FEBS Lett; 2012 Mar; 586(6):766-71. PubMed ID: 22293503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shear stress-mediated changes in the expression of complement regulatory protein CD59 on human endothelial progenitor cells by ECM-integrinα
    Cui X; Zhang X; Bu H; Liu N; Li H; Guan X; Yan H; Wang Y; Zhang H; Ding Y; Cheng M
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):416-421. PubMed ID: 28943429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation of the complement susceptibility of the rat aortic smooth muscle cell line A7r5.
    Capey S; Mosedale JG; van den Berg CW
    Mol Immunol; 2007 Jan; 44(4):608-14. PubMed ID: 16516969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of multiple transgenic Yucatan miniature pigs expressing human complement regulatory factors, human CD55, CD59, and H-transferase genes.
    Jeong YH; Park CH; Jang GH; Jeong YI; Hwang IS; Jeong YW; Kim YK; Shin T; Kim NH; Hyun SH; Jeung EB; Hwang WS
    PLoS One; 2013; 8(5):e63241. PubMed ID: 23704897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralization of complement regulatory proteins CD55 and CD59 augments therapeutic effect of herceptin against lung carcinoma cells.
    Zhao WP; Zhu B; Duan YZ; Chen ZT
    Oncol Rep; 2009 Jun; 21(6):1405-11. PubMed ID: 19424617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination treatment with lipoteichoic acids isolated from Lactobacillus plantarum and Staphylococcus aureus alleviates atopic dermatitis via upregulation of CD55 and CD59.
    Kim Y; Lee YD; Kim M; Kim H; Chung DK
    Immunol Lett; 2019 Oct; 214():23-29. PubMed ID: 31454521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
    Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59.
    Leaderer D; Cashman SM; Kumar-Singh R
    J Gene Med; 2015; 17(6-7):101-15. PubMed ID: 25917932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
    Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
    J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.